Peggy Scherle insider trades
Open-market stock purchases and sales by Peggy Scherle, Chief Scientific Officer at Prelude Therapeutics Inc, from SEC Form 4 filings since Apr 7, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 4, 2026 | PRLD Prelude Therapeutics Inc | Bought (not open market) | — |
Companies traded
- PRLD Prelude Therapeutics Inc: 17 sales, last Feb 4, 2026